Clinical study on modified Banxia Xiexin decoction in the treatment of simple Obesity in Children

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2100005244

Enrollment

Unknown

Registered

2021-08-28

Start date

2021-09-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Simple obesity in children

Interventions

Control group:Diet and exercise management+placebo

Test group:Diet and exercise management+Banxia Xiexin decoction

Eligibility

Sex/Gender

All

Age

7 Years to 14 Years

Inclusion criteria

Inclusion criteria: ? Meet the diagnostic criteria of simple obesity in children; ? Age 7-14 years; ? The legal guardian of the child signed the informed consent form; ? It is consistent with the children with strong stomach and weak spleen in children with simple obesity.

Exclusion criteria

Exclusion criteria: ? Those who used drugs in recent 3 months; (2) suffering from congenital metabolic or genetic diseases, liver and kidney diseases, infectious diseases such as AIDS and active tuberculosis. ? Participating in clinical trials of other drugs.

Design outcomes

Primary

Measure	Time frame
WHR;BMI;	—

Secondary

Measure	Time frame
blood sugar;uric acid;TCM Syndrome Scale;insulin;blood fat;	—

Countries

China

Contacts

Public ContactZheng Hong

drzhenghs@126.com18937153029

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026